Abstract

BackgroundThe tuberculin skin test (TST) identifies individuals at high risk of developing tuberculosis (TB) but poses many challenges. The blood monocyte-to-lymphocyte ratio (MLR) could be an alternative, as extremes in MLR have been associated with increased risk of TB disease.MethodsAt a primary care clinic in Johannesburg, a differential white blood cell count and TST was performed in adults starting antiretroviral treatment (ART) without symptoms suggestive of active TB.ResultsOf 259 participants, 171 had valid results of whom 30% (51/171) were TST positive and the median MLR was 0.18 (IQR 0.13–0.28). The MLR distribution differed between CD4 count categories (p < 0.01), with a broader range of values in TST negative participants with a low CD4 count (≤ 250 cells/mm3), likely reflecting HIV immunosuppression. MLR was associated with a positive TST (OR 0.78 per 0.1 increase, 95% CI 0.59, 0.97) in bivariate analysis but not in multivariate regression analysis (aOR 0.83 for every 0.1 increase, 95% CI 0.60, 1.08).ConclusionIn ART-naïve adults without symptoms suggestive of active TB, MLR was not independently associated with TST positivity and is thus unlikely to be a useful alternative to TST. Future research should focus on development of a cheap, simple and accurate biomarker to identify those people benefiting most from preventive TB therapy.

Highlights

  • TB remains a global public health threat, with 10 million new tuberculosis (TB) cases and 1.5 million TB deaths annually worldwide [1]

  • The monocyte-to-lymphocyte ratio (MLR) distribution differed between CD4 count categories (p < 0.01), with a broader range of values in TST negative participants with a low CD4 count ( 250 cells/mm3), likely reflecting HIV immunosuppression

  • MLR was associated with a positive TST in bivariate analysis but not in multivariate regression analysis

Read more

Summary

Introduction

TB remains a global public health threat, with 10 million new tuberculosis (TB) cases and 1.5 million TB deaths annually worldwide [1]. Among people living with HIV, TB remains an important cause of morbidity and mortality with almost a million TB cases and a quarter million TB deaths in 2018 despite the impressive global roll-out of antiretroviral therapy (ART) [1]. The tuberculin skin test (TST), a surrogate of infection with Mycobacterium tuberculosis, has been widely used to identify people at increased risk of developing TB disease [3]. An important challenge to effective use of either TST or IGRA is the reduced sensitivity in ART-naïve individuals living with HIV due to HIV immunosuppression [7]. The tuberculin skin test (TST) identifies individuals at high risk of developing tuberculosis (TB) but poses many challenges. The blood monocyte-to-lymphocyte ratio (MLR) could be an alternative, as extremes in MLR have been associated with increased risk of TB disease

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call